Our laboratory utilized NGS and identified activating TYK2 mutations in malignant peripheral nerve sheath tumors (MPNST), an aggressive subtype of sarcomas associated with the Neurofibromatosis type 1 (NF1) cancer predisposition syndrome [36]. The gene discussed is TYK2; the disease is malignant peripheral nerve sheath tumor.